{
  "report_rows": [
    {
      "kpi": "Total revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.642B vs. cons $1.624B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$3.11 vs. cons $3.008",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Chemistry revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$173.0M vs. cons $171.9M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 total revenue",
      "prediction": "UNCHANGED",
      "answer": "guide ~$6.405B-$6.455B vs. cons $6.445B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$14.40-$14.60 vs. cons $14.522",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$3.95-$4.05 vs. cons $3.996",
      "confidence": "LOW"
    },
    {
      "kpi": "Forward commentary",
      "prediction": "UNCHANGED",
      "answer": "reiterate synergy/cost-savings timing; cautious BD China tone vs. UNVERIFIED comparator",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -2.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -3.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 B-type package with limited out-period revision",
  "day5_confidence": "LOW"
}